Supplementary Methods

Gene Ontology (GO) analysis with background correction for expressed genes
The GO annotation was queried via the EnrichR API in R (1). A customized background gene list is required for the proper calculation of over-and under-representation of a GO term (2) . For the alternative splicing analysis in this study, the background genes were selected by having sufficient coverage at splice junctions to meet the filtering criteria described above. With this customized background list, a corrected p-value can be computed using the hypergeometric test. The Benjamini-Hochberg procedure was used to control for the false discovery rate (FDR) at 5%. To reduce complexity, the resulting GO terms were required to contain at least 10 genes, with an exception for Figure 2B , where the minimum term size was increased to 100 to display the most representative terms. To visualize GO results, the REVIGO web server was employed with customized R plotting scripts for Figures 3 and 6 (3).
Overlap enrichment assessment
Hypergeometric test p-value is used to measure the significance of the overlap between two groups of alternative splicing events. The triple intersection p-value is calculated by R package "SuperExactTest" based on hypergeometric test (4).
Breast cancer and lung cancer Myc-correlated alternative splicing analysis
The RNA-Seq processing framework described above was applied to quantify gene expression and alternative splicing of GTEx normal breast and lung samples, and TCGA BRCA and LUAD tumor-adjacent normal samples and tumor samples that are matched to tumor-adjacent normal samples. These datasets are de-identified. The Myc pathway-dependent splicing analysis was performed as described above.
Lentiviral constructs
The myrAKT1 lentiviral vector has been described previously (5) . The inducible Myc lentiviral vector was cloned by inserting MYC into the BamHI site of the PSTV lentiviral backbone. Lentiviruses were prepared and titered as described (5) .
Organotypic human prostate transformation assay
This assay was conducted as previously described (6, 7) with de-identified human prostate samples. Doxycycline (1 ug/mL, Calbiochem 324385) was added to all culture media and renewed every 3 days.
Xenograft outgrowth of transformed cells and cell line derivation
The xenograft and cell line derivation protocols have been previously described and were modified only to accommodate the doxycyline-inducible vector (6, 7) . Mice were fed sterile doxycycline chow (Bio-Serv S3888) continuously starting 3 days before xenograft implantation. Cell line initiation was performed on harvested tumors with the addition of 1 ug/mL doxycycline to all media.
Cell line exon annotations
Exon annotations of known stop codons and the middle exon length were generated based on the same GENCODE gene annotation file used for alignment. Potential frameshift annotation is determined if the middle exon length cannot be divided by three. Potential RNA binding proteins were labeled according to the GO annotation term 'RNA binding'.
Cell line propagation
The engineered cell lines were grown in stem cell media, composed of advanced DMEM/F12K (Gibco 12634028) base media with addition of B27 (Gibco 17504044), EGF (10 ng/mL, Peprotech 100-47), and FGF2 (10 ng/mL, Peprotech 100-18B) as well as Glutamax (Gibco 35050061). Doxycycline (1 ug/mL) was added to cultures to maintain MYC expression. Media was renewed every 3 days.
Myc withdrawal experiments
Cells were collected by centrifugation and washed with media three times to remove doxycycline. 1 million cells were plated for each condition. Doxycycline was added back to the appropriate wells and then harvested at the appropriate time point (0-24 h).
Histology
Portions of xenograft outgrowths were fixed in formalin overnight and transferred to 70% ethanol solution before submission for further processing by the Tissue Procurement Core Laboratory at UCLA (TPCL). Organoids were collected by dispase dissociation from Matrigel, washed three times with PBS, and then formalin-fixed for 30 min at room temperature. The fixed organoids were again collected by centrifugation and resuspended in HistoGel and submitted to TPCL. All samples were paraffin-embedded, sectioned at 4 µm, and mounted on glass slides. Hematoxylin and eosin staining was conducted according to standard protocols.
Immunohistochemistry
Immunohistochemical studies were conducted as previously described (7) . Briefly, unstained slides were subjected to deparaffinization, rehydration, and heat-activated citric acid antigen retrieval. Rehydrated slides were blocked with 1% horse serum in PBS before overnight incubation with primary antibodies also diluted in 1% horse serum/PBS. Primary and secondary antibodies and their dilutions are listed below. Antibody binding was detected using an HRPconjugated secondary antibody and a chromogenic substrate.
Immunoblotting
Portions of tumor xenografts or 10 million cultured cells were placed in 8M urea lysis buffer with protease inhibitors (Sigma-Aldrich 4693159001) and homogenized with a Dounce apparatus. The lysate was cleared by ultracentrifugation at 30,000 x g for 30 min. Samples were denatured by boiling in SDS loading buffer under reducing conditions for 1 min and subjected to polyacrylamide gel electrophoresis. Wet transfer to nitrocellulose membrane was followed by blocking in 1% milk/0.1% Tween/PBS and overnight primary antibody incubation at 5 °C in the same buffer. HRPconjugated secondary antibodies were applied after washing and the blot visualized with a proluminescent substrate. Semi-quantitative blots of SRSF3 protein levels used PVDF membrane. Fluorescence levels were measured by Typhoon scanner and normalized to GAPDH levels. Antibody sources and dilutions are described below.
Antibodies for flow cytometry, immunohistochemistry and immunoblotting
Antibodies used for flow cytometry were the fluorochrome conjugates CD49f-PE (12-0495-82; eBiosciences) and Trop2-APC (FAB650A; R&D Systems).
Primary antibodies used for immunohistochemistry included CK8 (1:1,000, Covance MMS-162P), AR (1:250, Santa Cruz sc-816), PSA (KLK3) (1:2000, Dako A0562), CK5 (1:1000, Covance PRB-160P), and p63 (1:250, Santa Cruz sc-8431). Secondary antibodies used were ImmPRESS anti-rabbit Ig peroxidase and anti-mouse Ig peroxidase (Vector Labs). Liquid DAB+ substrate reagent (Dako) was used to perform direct chromogenic visualization.
The following primary antibodies were used for immunoblotting (all at 1:1000 dilution, unless otherwise noted): Myc (Abcam ab32072), pan-AKT (Cell Signaling 4691), p53 (Cell Signaling Technology 2527), PARP1 (AbCam ab32138), cleaved PARP1 (AbCam, ab32064), anti-Cdk2 (AbCam ab32147), anti-Cdk2 (phospho Y15) (AbCam ab76146), p21 anti-p21 [EPR3993] (ab109199), and GAPDH (1:5,000, GeneTex GT239). HRP-conjugated goat anti-rabbit and goatanti-mouse secondary antibodies (BioRad) were used for luminescent detection. For semiquantitative Western blots, goat anti-mouse-cy5 (1:5000, Sigma-Aldrich GEPA45009) was used.
Cell cycle analysis
One million cells were withdrawn from doxycycline as described above and harvested by centrifugation at the appropriate time-point. Cell pellets were washed three times with PBS and then singly dissociated with trypsin prior to fixation in 10% cold ethanol. After overnight fixation at 5° C, cells were pelleted and rehydrated in PBS. RNAse was added and the suspension incubated at room temperature for 4 h before staining with 20 ng/mL 7AAD and analysis by flow cytometry.
Cell growth assay
Cells were washed with PBS, withdrawn from doxycycline, and plated at a density of 100,000 cells per well. Cells were lysed with CellTiterGlo luciferase reagent at the appropriate time and submitted for luminometry.
Whole transcriptome sequencing analysis
Total RNA was isolated by guanidinium thiocyanate-phenol-chloroform extraction, followed by column clean-up. Isolated RNA was submitted for RNA integrity number (RIN) analysis. Only samples with RIN > 9 were carried forward. cDNA libraries were prepared from isolated RNA after poly-A selection using the TruSeq RNA Sample Prep Kit v2 (Illumina). High-throughput sequencing with 150 bp paired-end reads was performed using an Illumina HiSeq 2500. At least 100 million reads were collected for each sample.
Cell line exon annotations
Exon annotations of known stop codons and the middle exon length were generated based on the same GENCODE gene annotation file used for alignment. Potential frameshift annotation is determined if the middle exon length cannot be divided by three. Potential RNA binding proteins were labeled according to the GO annotation term 'RNA binding'. Fig. S1 . Comparison of count-based and ratio-based isoform-level analyses of prostate RNA-Seq datasets. (A) Unsupervised analysis of count-based isoform expression from a combined prostate cancer dataset (left panel). The same methodology applied to the ratio-based alternative splicing approach from Figure 1B Quantitation is the average reduction in SRSF3 levels measured in each cell line over the three independent replicates shown.
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